PORCILIS PCV M HYO

Product Description

COMPOSITION: Each 2 ml contains:
Porcine circovirus type 2 (PCV2) ORF2 subunit antigen………………… ≥ 2,828 AU∗
Mycoplasma hyopneumoniae J strain inactivated …………………………..≥ 2.69 RPU∗∗

∗Antigenic units as determined in the in vitro potency test (ELISA).∗∗ Relative potency units defined against a reference vaccine.

INDICATIONS:

For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (PCV2) infection, and severity of lung lesions caused by Mycoplasma hyopneumoniae infection. To reduce the loss of daily weight gain during the finishing period in face of infections with Mycoplasma hyopneumoniae and/or PCV2 (as observed in field studies).

Onset of immunity with single dose vaccination:
PCV2: 2 weeks after vaccination
M. hyopneumoniae: 4 weeks after vaccination.

Onset of immunity with two dose vaccination:
PCV2: 18 days after first vaccination
M. hyopneumoniae: 3 weeks after the second vaccination.

Duration of immunity (both vaccination schedules):
PCV2: 22 weeks after (the last) vaccination
M. hyopneumoniae: 21 weeks after (the last) vaccination.

DOSAGE:

A single dose (2 ml) of Porcilis Lawsonia mixed with Porcilis PCV M Hyo is given intramuscularly in the neck.
Visual appearance after reconstitution: homogenous white to nearly white emulsion after shaking.

PRECAUTIONS:
Vaccinate healthy animals only.

WITHDRAWAL PERIOD:
Zero days.

PRESERVATION:

Keep out of the reach and sight of children.
Store and transport refrigerated (2 °C – 8 °C), in the dark and dry place.

PRESENTATIONS:

50 mL/25 doses
100 mL/50 doses
200 mL/100 doses.

FOR VETERINARY USE ONLY

MANUFACTURED: USA.